메뉴 건너뛰기




Volumn 10, Issue 2, 1999, Pages 79-87

"Sacred" research practices we may want to change

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CHILD; ETHICS; FEMALE; FREEDOM; HUMAN; HUMAN EXPERIMENT; INTERNATIONAL COOPERATION; MEDICAL ETHICS; MINORITY GROUP; MISCELLANEOUS NAMED GROUPS; NOTE; PATIENT PARTICIPATION; PATIENT SELECTION; PERSONAL AUTONOMY; RESEARCH; RESEARCH ETHICS; RESEARCH SUBJECT; SEX DIFFERENCE; SOCIAL CHANGE; SOCIAL PSYCHOLOGY; STANDARD; UNITED STATES; VULNERABLE POPULATION; WOMEN'S HEALTH;

EID: 0033138730     PISSN: 10467890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (3)

References (8)
  • 1
    • 8744295103 scopus 로고    scopus 로고
    • Research Advances in Psychiatry
    • Paper presented 17 May in Washington, D.C.
    • The use of thalidomide in female subjects resulted in severe birth defects in some of their infants, for example. Also, animal models tend to be based on males, as females have rapid menstrual cycles that can alter research findings. A.F. Schatzberg, "Research Advances in Psychiatry," (Paper presented at the American Psychiatric Association 1999 Annual Meeting, 17 May 1999, in Washington, D.C.). Whether even these reasons are good ones is - especially with the benefit of hindsight - subject to debate.
    • (1999) American Psychiatric Association 1999 Annual Meeting
    • Schatzberg, A.F.1
  • 2
    • 8744230063 scopus 로고    scopus 로고
    • note
    • For example, I can recall no instance in meetings of different IRBs, over literally decades, in which principal investigators have protested as vigorously as they have when informed that an IRB would not approve their protocol because it did not include women. As a second example, I recently attended a conference at which the presenters were describing new requirements to include children. The attendees' chagrin was so strong, even the presenters hastened to assure them there were many ways that researchers could "get around them."
  • 3
    • 8744246527 scopus 로고    scopus 로고
    • Childhood Maltreatment and Adverse Outcomes: A Prospective Developmental Approach
    • Paper presented 18 May in Washington, B.C.
    • Emphasis added. The following example illustrates how far we are from this now: Children subjected to sexual abuse are among those worst-off. There are more new cases of children subjected to sexual abuse each year than all new cancer cases combined, and the costs to society of child abuse and cancer are surprisingly commensurate. Nonetheless, the research dollars we will spend this year on child abuse are $29.9 million; on cancer, $3.1 billion. The annual cost from child abuse is estimated to be $56 billion dollars. F.W. Putnam, "Childhood Maltreatment and Adverse Outcomes: A Prospective Developmental Approach," (Paper presented at the American Psychiatric Association Meeting, 18 May 1999, in Washington, B.C.).
    • (1999) American Psychiatric Association Meeting
    • Putnam, F.W.1
  • 4
    • 0032086621 scopus 로고    scopus 로고
    • The Ethics of Placebo-Controlled Trials for Perinatal Transmission of HIV in Developing Countries
    • Summer
    • See, e.g., P.A. Clark, ""The Ethics of Placebo-Controlled Trials for Perinatal Transmission of HIV in Developing Countries," The Journal of Clinical Ethics 9, no. 2 (Summer 1998): 156-66, and R.J. Levine, "The 'Best Proven Therapeutic Method' Standard in Clinical Trials in Technologically Developing Countries," The Journal of Clinical Ethics 9, no. 2 (Summer 1998): 167-72.
    • (1998) The Journal of Clinical Ethics , vol.9 , Issue.2 , pp. 156-166
    • Clark, P.A.1
  • 5
    • 0032087564 scopus 로고    scopus 로고
    • The 'Best Proven Therapeutic Method' Standard in Clinical Trials in Technologically Developing Countries
    • Summer
    • See, e.g., P.A. Clark, ""The Ethics of Placebo-Controlled Trials for Perinatal Transmission of HIV in Developing Countries," The Journal of Clinical Ethics 9, no. 2 (Summer 1998): 156-66, and R.J. Levine, "The 'Best Proven Therapeutic Method' Standard in Clinical Trials in Technologically Developing Countries," The Journal of Clinical Ethics 9, no. 2 (Summer 1998): 167-72.
    • (1998) The Journal of Clinical Ethics , vol.9 , Issue.2 , pp. 167-172
    • Levine, R.J.1
  • 6
    • 4243939649 scopus 로고    scopus 로고
    • A Low-Cost Way to Cut Mother-to-Child HIV?
    • 15 July
    • D. Brown, "A Low-Cost Way to Cut Mother-to-Child HIV?" Washington Post, 15 July 1999, A4.
    • (1999) Washington Post
    • Brown, D.1
  • 7
    • 0032199750 scopus 로고    scopus 로고
    • Research in Developing Countries: Taking 'Benefit' Seriously
    • November-December
    • L.H. Glantz et al., "Research in Developing Countries: Taking 'Benefit' Seriously," Hastings Center Report 28, no. 6 (November-December 1998): 38-42.
    • (1998) Hastings Center Report , vol.28 , Issue.6 , pp. 38-42
    • Glantz, L.H.1
  • 8
    • 0027741044 scopus 로고
    • Malignant Hyperthermia and Associated Disorders
    • Mortality, if untreated, exceeds 80 percent. With other measures, including dantrolene, this figure may be less than 7 percent. G.C. Allen, "Malignant Hyperthermia and Associated Disorders," Current Opinion in Rheumatology 5 (1993): 719-24.
    • (1993) Current Opinion in Rheumatology , vol.5 , pp. 719-724
    • Allen, G.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.